ORLANDO, Fla., Aug. 23, 2018 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a pharmaceutical company developing and commercializinga portfolio of prescription pharmaceuticals, OTC's and consumer products based around the science of transdermal/topical technologies, announced today that Gareth Sheridan, CEO, will host an audio and video webinar, slide
Mr. Sheridan will discuss various key events for Nutriband, among them the acquisition in April 2018 of 4P Therapeutics Inc., a company focusing on transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics, and the transformation of 4P Therapeutics into the Pharmaceutical and Development arm of Nutriband. Mr. Sheridan will also talk about Nutriband's recent appointments to its Advisory Board, among them Sean Gallagher, a former candidate for the presidency of Ireland, who now serves as president of Nutriband.
To view the webinar, please visit https://www.redchip.com/events.
About Nutriband Inc.Nutriband is a health and pharmaceutical company based in Orlando, Florida. With the acquisition of 4P, Nutriband now has a pipeline of potential transdermal products in various stages of development. All Nutriband products are based around the science of transdermal/topical technologies. Nutriband's website is www.nutriband.com.
About Our Forward-Looking StatementsCertain statements contained in this press release, including, without limitation, statements containing the words "believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. Our actual results may differ materially from those anticipated in our forward-looking statements as a result of a number of factors, including our ability to develop and market new products; our ability to complete the necessary testing in order to obtain regulatory approval; the safety and efficacy of any products we develop, our ability to obtain necessary financial to complete the regulatory process and market any products that we develop, our ability to create, sustain, manage or forecast our growth; our ability to attract and retain key personnel; changes in our business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions. Except as required by applicable law, we undertake no obligation to revise or update any of our forward-looking statements in order to reflect any event or circumstance that may arise after the date hereof. Information on our website or any other website does not constitute a part of this press release.
For more information, contact:
Gareth Sheridan CEONutriband Inc.(407) firstname.lastname@example.org www.nutriband.com
Victor RobertsRedChip Companies (407) email@example.com
View original content:http://www.prnewswire.com/news-releases/nutriband-inc-otcqb-ntrb-to-host-investor-webinar-to-discuss-acquisition-of-4p-therapeutics-inc--other-important-recent-developments-300701338.html
SOURCE Nutriband Inc.
Subscribe to our Free Newsletters!